Independent schools: Challenges and choices
ArticleAt a time of profound change for independent schools, we look at key issues leadership teams are grappling with and how our multi-disciplinary team can help.

Buy-and-build strategies can open up access to new markets, services and geographies, and enhance the value of your business. To maximise the chances of success, buy-side expertise and global capabilities are a given.
Listening closely and working in collaboration, we'll help you develop and execute your acquisition strategy – including finding targets, negotiating terms, raising funding, and achieving successful completion and integration.
M&A strategy development with a focus on driving value for your business.
Sourcing, approaching, valuing and completing an acquisition in line with your goals.
End-to-end support and tailored buy-side advice to guide you throughout the transaction.
You’ll work with a highly experienced, dedicated team with hands-on support and strategic advice to develop and execute your acquisition strategy.
You’ll get insight from market-leading M&A advisers, as well as our national and international network, to ensure you find the right acquisition – and are fully supported throughout.
Our pedigree in mid-market and international transactions means we're best-placed to deliver the right outcomes for you.
![]()
At a time of profound change for independent schools, we look at key issues leadership teams are grappling with and how our multi-disciplinary team can help.
Celebrating the UK’s top privately-owned clinical services companies and exploring key trends
Baking exit-readiness into day-to-day business can improve performance and drive value. Our experts outline how and highlight overlooked areas of sale preparation.
200 of the fastest-growing privately owned manufacturing businesses across Great Britain.
On the 3rd July 2025, the Labour government published its 10-year health plan for the NHS, setting out its vision to transform how healthcare is delivered across England. For health tech innovators, this is not just a policy, it’s a game-changing opportunity. Our experts Will Rose and Jessica Sandercock outline the key details of the plan and its impact on Health Tech in the UK.
I am pleased to share that 2025 was another strong-performing year for the Grant Thornton Deals team in the UK. Whilst market headwinds from geopolitical events to the uncertainty around the budget had some impact on investor appetite, the year finished with good momentum. The team successfully completing X deals, with a cumulative value of £X.